{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T03:37:30Z","timestamp":1764905850378},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T00:00:00Z","timestamp":1557187200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00393-019-0644-5","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T19:21:51Z","timestamp":1557256911000},"page":"620-626","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["MTX-Intoleranz bei Kindern und Jugendlichen mit juveniler idiopathischer Arthritis"],"prefix":"10.1007","volume":"78","author":[{"given":"B.","family":"H\u00fcgle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,7]]},"reference":[{"issue":"13","key":"644_CR1","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1001\/jama.294.13.1671","volume":"294","author":"PJ Hashkes","year":"2005","unstructured":"Hashkes PJ, Laxer RM (2005) Medical treatment of juvenile idiopathic arthritis. JAMA 294(13):1671\u20131684","journal-title":"JAMA"},{"issue":"12","key":"644_CR2","first-page":"2501","volume":"31","author":"O Ortiz-Alvarez","year":"2004","unstructured":"Ortiz-Alvarez O, Morishita K, Avery G, Green J, Petty RE, Tucker LB, Malleson PN, Cabral DA (2004) Guidelines for blood test monitoring of methotrexate toxicity in juvenile idiopathic arthritis. J\u00a0Rheumatol 31(12):2501\u20132506","journal-title":"J Rheumatol"},{"issue":"4","key":"644_CR3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1756-185X.2010.01564.x","volume":"13","author":"AN Malaviya","year":"2010","unstructured":"Malaviya AN, Sharma A, Agarwal D, Kapoor S, Garg S, Sawhney S (2010) Low-dose and high-dose methotrexate are two different drugs in practical terms. Int J Rheum Dis 13(4):288\u2013293","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"644_CR4","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1002\/art.20278","volume":"50","author":"JM Kremer","year":"2004","unstructured":"Kremer JM (2004) Toward a\u00a0better understanding of methotrexate. Arthritis Rheum 50(5):1370\u20131382","journal-title":"Arthritis Rheum"},{"issue":"6","key":"644_CR5","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1172\/JCI116884","volume":"92","author":"BN Cronstein","year":"1993","unstructured":"Cronstein BN, Naime D, Ostad E (1993) The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J\u00a0Clin Invest 92(6):2675\u20132682","journal-title":"J Clin Invest"},{"issue":"6","key":"644_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2165\/00148581-200608060-00003","volume":"8","author":"T Niehues","year":"2006","unstructured":"Niehues T, Lankisch P (2006) Recommendations for the use of methotrexate in juvenile idiopathic arthritis. Paediatr Drugs 8(6):347\u2013356","journal-title":"Paediatr Drugs"},{"issue":"4","key":"644_CR7","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0889-857X(05)70362-8","volume":"23","author":"BH Singsen","year":"1997","unstructured":"Singsen BH, Goldbach-Mansky R (1997) Methotrexate in the treatment of juvenile rheumatoid arthritis and other pediatric rheumatoid and nonrheumatic disorders. Rheum Dis Clin North Am 23(4):811\u2013840","journal-title":"Rheum Dis Clin North Am"},{"key":"644_CR8","first-page":"CD000951","volume":"5","author":"B Shea","year":"2013","unstructured":"Shea B, Swinden MV, Tanjong Ghogomu E, Ortiz Z, Katchamart W, Rader T, Bombardier C, Wells GA, Tugwell P (2013) Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database Syst Rev 5:CD951","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"644_CR9","first-page":"480","volume":"25","author":"A van der Meer","year":"2007","unstructured":"van der Meer A, Wulffraat NM, Prakken BJ, Gijsbers B, Rademaker CM, Sinnema G (2007) Psychological side effects of MTX treatment in juvenile idiopathic arthritis: A\u00a0pilot study. Clin Exp Rheumatol 25(3):480\u2013485","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"644_CR10","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1002\/art.30367","volume":"63","author":"M Bulatovi\u0107","year":"2011","unstructured":"Bulatovi\u0107 M, Heijstek MW, Verkaaik M, van Dijkhuizen EH, Armbrust W, Hoppenreijs EP, Kamphuis S, Kuis W, Egberts TC, Sinnema G et\u00a0al (2011) High prevalence of methotrexate intolerance in juvenile idiopathic arthritis: Development and validation of a methotrexate intolerance severity score. Arthritis Rheum 63(7):2007\u20132013","journal-title":"Arthritis Rheum"},{"issue":"6","key":"644_CR11","doi-asserted-by":"publisher","first-page":"R217","DOI":"10.1186\/ar4413","volume":"15","author":"MB \u0106alasan","year":"2013","unstructured":"\u0106alasan MB, van den Bosch OF, Creemers MC, Custers M, Heurkens AH, van Woerkom JM, Wulffraat NM (2013) Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis. Arthritis Res Ther 15(6):R217","journal-title":"Arthritis Res Ther"},{"key":"644_CR12","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ejphar.2013.09.071","volume":"722","author":"C Kamen","year":"2014","unstructured":"Kamen C, Tejani MA, Chandwani K, Janelsins M, Peoples AR, Roscoe JA, Morrow GR (2014) Anticipatory nausea and vomiting due to chemotherapy. Eur J Pharmacol 722:172\u2013179","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"644_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12969-016-0099-z","volume":"14","author":"J Fr\u00e1\u0148ov\u00e1","year":"2016","unstructured":"Fr\u00e1\u0148ov\u00e1 J, Fingerhutov\u00e1 S, Kobrov\u00e1 K, Srp R, N\u011bmcov\u00e1 D, Hoza J, Uher M, Saifridov\u00e1 M, Linkov\u00e1 L, Dole\u017ealov\u00e1 P (2016) Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration. Pediatr Rheumatol Online\u00a0J 14(1):36","journal-title":"Pediatr Rheumatol Online J"},{"issue":"6","key":"644_CR14","first-page":"901","volume":"56","author":"A Scheuern","year":"2017","unstructured":"Scheuern A, Tyrrell PN, Haas J\u2011P, H\u00fcgle B (2017) Countermeasures against methotrexate intolerance in juvenile idiopathic arthritis instituted by parents show no effect. Rheumatology (Oxford) 56(6):901\u2013906","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"644_CR15","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10067-013-2389-x","volume":"33","author":"P Patil","year":"2014","unstructured":"Patil P, Parker RA, Rawcliffe C, Olaleye A, Moore S, Daly N, Sen D, Ioannou Y (2014) Methotrexate-induced nausea and vomiting in adolescent and young adult patients. Clin Rheumatol 33(3):403\u2013407","journal-title":"Clin Rheumatol"},{"issue":"1","key":"644_CR16","first-page":"148","volume":"34","author":"EH van Dijkhuizen","year":"2016","unstructured":"van Dijkhuizen EH, Pouw JN, Scheuern A, H\u00fcgle B, Hardt S, Ganser G, K\u00fcmmerle-Deschner JB, Horneff G, Holzinger D, Bulatovi\u0107 \u0106alasan M et al (2016) Methotrexate intolerance in oral and subcutaneous administration in patients with juvenile idiopathic arthritis: A cross-sectional, observational study. Clin Exp Rheumatol 34(1):148\u2013154","journal-title":"Clin Exp Rheumatol"},{"issue":"1\/2","key":"644_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.autneu.2006.07.012","volume":"129","author":"U Stockhorst","year":"2006","unstructured":"Stockhorst U, Steingrueber HJ, Enck P, Klosterhalfen S (2006) Pavlovian conditioning of nausea and vomiting. Auton Neurosci 129(1\/2):50\u201357","journal-title":"Auton Neurosci"},{"issue":"3","key":"644_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1136\/adc.88.3.197","volume":"88","author":"AV Ramanan","year":"2003","unstructured":"Ramanan AV, Whitworth P, Baildam EM (2003) Use of methotrexate in juvenile idiopathic arthritis. Arch Dis Child 88(3):197\u2013200","journal-title":"Arch Dis Child"},{"issue":"9","key":"644_CR19","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/rheumatology\/39.9.975","volume":"39","author":"A Maetzel","year":"2000","unstructured":"Maetzel A, Wong A, Strand V, Tugwell P, Wells G, Bombardier C (2000) Meta-analysis of treatment termination rates among rheumatoid arthritis patients receiving disease-modifying anti-rheumatic drugs. Rheumatology 39(9):975\u2013981","journal-title":"Rheumatology"},{"issue":"2","key":"644_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/FPC.0b013e32834ded2a","volume":"22","author":"KP Spyridopoulou","year":"2012","unstructured":"Spyridopoulou KP, Dimou NL, Hamodrakas SJ, Bagos PG (2012) Methylene tetrahydrofolate reductase gene polymorphisms and their association with methotrexate toxicity: A\u00a0meta-analysis. Pharmacogenet Genomics 22(2):117\u2013133","journal-title":"Pharmacogenet Genomics"},{"issue":"1","key":"644_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12969-016-0071-y","volume":"14","author":"A Scheuern","year":"2016","unstructured":"Scheuern A, Fischer N, McDonald J, Brunner HI, Haas JP, H\u00fcgle B (2016) Mutations in the MTHFR gene are not associated with methotrexate intolerance in patients with juvenile idiopathic arthritis. Pediatr Rheumatol Online\u00a0J 14(1):11","journal-title":"Pediatr Rheumatol Online J"},{"key":"644_CR22","volume-title":"Are single nucleotide polymorphisms in methotrexate transporter proteins associated with methotrexate intolerance in juvenile idiopathic arthritis? [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 10)","author":"N Kyvsgaard","year":"2018","unstructured":"Kyvsgaard N, Mikkelsen T, Estmann A, Als T, Hvarregaard Christensen J, Corydon T, Herlin T (2018) Are single nucleotide polymorphisms in methotrexate transporter proteins associated with methotrexate intolerance in juvenile idiopathic arthritis? [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 10). https:\/\/acrabstracts.org\/abstract\/are-single-nucleotide-polymorphisms-in-methotrexate-transporter-proteins-associated-with-methotrexate-intolerance-in-juvenile-idiopathic-arthritis\/ . Zugegriffen: 29. Apr. 2019"},{"key":"644_CR23","volume-title":"Disruptions in folate homeostasis may lead to increased risk for methotrexate intolerance in juvenile idiopathic arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10)","author":"ML Becker","year":"2015","unstructured":"Becker ML, van Haandel L, Funk R, Gaedigk R, Leeder JS (2015) Disruptions in folate homeostasis may lead to increased risk for methotrexate intolerance in juvenile idiopathic arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https:\/\/acrabstracts.org\/abstract\/disruptions-in-folate-homeostasis-may-lead-to-increased-risk-for-methotrexate-intolerance-in-juvenile-idiopathic-arthritis\/ . Zugegriffen: 30. Apr. 2019"},{"issue":"9","key":"644_CR24","doi-asserted-by":"publisher","first-page":"e107665","DOI":"10.1371\/journal.pone.0107665","volume":"9","author":"L Wendt","year":"2014","unstructured":"Wendt L, Albring A, Benson S, Engler H, Engler A, Hinney A, Rief W, Witzke O, Schedlowski M (2014) Catechol-O-methyltransferase Val158Met polymorphism is associated with somatosensory amplification and nocebo responses. PLoS ONE 9(9):e107665","journal-title":"PLoS ONE"},{"issue":"6","key":"644_CR25","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1080\/03009742.2016.1275775","volume":"46","author":"B H\u00fcgle","year":"2017","unstructured":"H\u00fcgle B, Scheuern A, Dollinger S, Fischer N, Haas J\u2011P (2017) Cathechol-O-methyltransferase Val158Met polymorphism is associated with nocebo effects, but not with methotrexate intolerance in patients with juvenile idiopathic arthritis. Scand J Rheumatol 46(6):502\u2013503","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"644_CR26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/MPG.0b013e31822855e7","volume":"53","author":"A Kempinska","year":"2011","unstructured":"Kempinska A, Benchimol EI, Mack A, Barkey J, Boland M, Mack DR (2011) Short-course ondansetron for the prevention of methotrexate-induced nausea in children with Crohn disease. J\u00a0Pediatr Gastroenterol Nutr 53(4):389\u2013393","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"644_CR27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10067-016-3398-3","volume":"36","author":"AN Malaviya","year":"2017","unstructured":"Malaviya AN (2017) Methotrexate intolerance in the treatment of rheumatoid arthritis (RA): Effect of adding caffeine to the management regimen. Clin Rheumatol 36(2):279\u2013285","journal-title":"Clin Rheumatol"},{"issue":"8","key":"644_CR28","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1002\/pbc.25063","volume":"61","author":"LL Dupuis","year":"2014","unstructured":"Dupuis LL, Robinson PD, Boodhan S, Holdsworth M, Portwine C, Gibson P, Phillips R, Maan C, Stefin N, Sung L et\u00a0al (2014) Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients. Pediatr Blood Cancer 61(8):1506\u20131512","journal-title":"Pediatr Blood Cancer"},{"issue":"Suppl. 10","key":"644_CR29","first-page":"1362","volume":"65","author":"E Ostermeier","year":"2013","unstructured":"Ostermeier E, Koetter H, Tony H, Pfister R (2013) iSyMind significantly reduces MTX-induced nausea in a\u00a0pilot trial. Arthritis Rheum 65(Suppl. 10):1362","journal-title":"Arthritis Rheum"},{"issue":"1","key":"644_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12969-018-0228-y","volume":"16","author":"L H\u00f6fel","year":"2018","unstructured":"H\u00f6fel L, Eppler B, Storf M, Schn\u00f6bel-M\u00fcller E, Haas JP, H\u00fcgle B (2018) Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing\u2014Treatment protocol and preliminary results. Pediatr Rheumatol Online\u00a0J 16(1):11","journal-title":"Pediatr Rheumatol Online J"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-019-0644-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-019-0644-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-019-0644-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T14:06:32Z","timestamp":1663423592000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-019-0644-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["644"],"URL":"https:\/\/doi.org\/10.1007\/s00393-019-0644-5","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,7]]},"assertion":[{"value":"7 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"B.\u00a0H\u00fcgle gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}